Employees Retirement System of Texas Purchases New Shares in Globus Medical, Inc. $GMED

Employees Retirement System of Texas acquired a new stake in shares of Globus Medical, Inc. (NYSE:GMED) during the 4th quarter, HoldingsChannel reports. The firm acquired 11,856 shares of the medical device company’s stock, valued at approximately $1,035,000.

A number of other hedge funds have also recently bought and sold shares of GMED. SBI Securities Co. Ltd. grew its stake in shares of Globus Medical by 98.2% in the 4th quarter. SBI Securities Co. Ltd. now owns 337 shares of the medical device company’s stock worth $29,000 after acquiring an additional 167 shares in the last quarter. Advisory Services Network LLC bought a new position in shares of Globus Medical during the third quarter valued at about $26,000. EverSource Wealth Advisors LLC boosted its holdings in Globus Medical by 74.3% during the second quarter. EverSource Wealth Advisors LLC now owns 462 shares of the medical device company’s stock worth $27,000 after purchasing an additional 197 shares during the last quarter. Larson Financial Group LLC boosted its holdings in Globus Medical by 83.4% during the fourth quarter. Larson Financial Group LLC now owns 532 shares of the medical device company’s stock worth $46,000 after purchasing an additional 242 shares during the last quarter. Finally, Parallel Advisors LLC grew its position in Globus Medical by 45.1% in the 3rd quarter. Parallel Advisors LLC now owns 557 shares of the medical device company’s stock worth $32,000 after purchasing an additional 173 shares in the last quarter. 95.16% of the stock is owned by hedge funds and other institutional investors.

Globus Medical Stock Down 2.9%

Shares of GMED stock opened at $82.60 on Thursday. The company has a 50 day moving average of $87.21 and a 200-day moving average of $88.47. Globus Medical, Inc. has a 12-month low of $51.79 and a 12-month high of $101.40. The firm has a market cap of $11.21 billion, a P/E ratio of 19.21, a PEG ratio of 1.76 and a beta of 1.00.

Globus Medical (NYSE:GMED) last posted its quarterly earnings results on Thursday, May 7th. The medical device company reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $0.92 by $0.20. Globus Medical had a net margin of 18.92% and a return on equity of 13.46%. The company had revenue of $759.85 million for the quarter, compared to analysts’ expectations of $740.35 million. During the same quarter in the previous year, the firm posted $0.68 EPS. Globus Medical’s revenue was up 27.0% on a year-over-year basis. Globus Medical has set its FY 2026 guidance at 4.700-4.800 EPS. As a group, equities analysts expect that Globus Medical, Inc. will post 4.74 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Barclays increased their price objective on shares of Globus Medical from $118.00 to $123.00 and gave the company an “overweight” rating in a research note on Wednesday, February 25th. Zacks Research raised Globus Medical from a “hold” rating to a “strong-buy” rating in a report on Tuesday, March 3rd. Truist Financial set a $115.00 price target on Globus Medical in a research report on Wednesday, February 25th. Needham & Company LLC boosted their price objective on Globus Medical from $114.00 to $117.00 and gave the stock a “buy” rating in a research report on Friday, May 8th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Globus Medical in a research note on Wednesday, April 15th. Two analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $106.36.

Globus Medical Profile

Globus Medical, Inc (NYSE:GMED) is a leading medical device company specializing in musculoskeletal solutions for spine and orthopaedic applications. Founded in 2003 by David C. Paul and headquartered in Audubon, Pennsylvania, the company develops, manufactures and markets implantable devices and surgical instruments designed to treat spinal disorders and promote bone healing. Its product portfolio encompasses solutions for minimally invasive and open surgical procedures, including interbody fusion devices, pedicle screw systems, and biologics used to enhance fusion outcomes.

In addition to its core spine business, Globus Medical has expanded into robotics and navigation systems to support precision and efficiency in the operating room.